Literature DB >> 10383022

Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.

K Honda1, K Nitta, S Horita, W Yumura, H Nihei, R Nagai, K Ikeda, S Horiuchi.   

Abstract

BACKGROUND: Ultra-filtration failure is a serious complication of long-term continuous ambulatory peritoneal dialysis (CAPD). This complication is related to histological changes of the peritoneum, i.e. severe interstitial fibrosis and microvascular sclerosis. Although their pathogenesis has not been elucidated yet, advanced glycation end products (AGEs) have been shown to accumulate in the peritoneal tissue of CAPD patients.
METHODS: Peritoneal biopsy specimens from 14 CAPD patients with low ultra-filtration (n = 9) and high ultra-filtration (n = 5) capacity were immunohistochemically investigated using a monoclonal antibody against AGEs (6D12). The severity of peritoneal fibrosis, microvascular sclerosis and intensity of AGE accumulation were semi-quantitatively evaluated. Peritoneal ultra-filtration capacity was evaluated by calculating daily ultrafiltration volume per body weight (UFV/BW) and D/D0 (glucose) of the peritoneal equilibration test.
RESULTS: In all patients with low ultra-filtration, AGE accumulated in the peritoneal fibrous tissue and microvascular walls. Remarkably, AGE accumulated more intensely in hyalinized fibrosis of small venular media. Extent of AGE accumulation in peritoneal interstitium and vascular walls correlated with the progression of interstitial fibrosis (rho = 0.727, P = 0.0088) and vascular sclerosis (rho = 0.915, P = 0.001). UFV/BW was inversely correlated to interstitial fibrosis (rho = -0.660, P = 0.0174), microvascular sclerosis (rho = -0.671, P = 0.0155) and microvascular AGE accumulation (rho = -0.678, P = 0.0145).
CONCLUSIONS: In CAPD patients, AGE formation in the peritoneum correlates with the development of severe interstitial fibrosis and microvascular sclerosis, which is associated clinically with impaired peritoneal ultra-filtration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383022     DOI: 10.1093/ndt/14.6.1541

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  32 in total

Review 1.  Mechanisms and interventions in peritoneal fibrosis.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2011-09-21       Impact factor: 2.801

Review 2.  Peritoneal damage by peritoneal dialysis solutions.

Authors:  Takafumi Ito; Noriaki Yorioka
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

3.  Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.

Authors:  El Rasheid Zakaria; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

4.  Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.

Authors:  Yasushi Otsuka; Masaaki Nakayama; Masato Ikeda; Ali M Sherif; Keitaro Yokoyama; Hiroyasu Yamamoto; Yoshindo Kawaguchi
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 5.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

6.  Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies.

Authors:  Gloria del Peso; José Antonio Jiménez-Heffernan; Rafael Selgas; César Remón; Marta Ossorio; Antonio Fernández-Perpén; José Antonio Sánchez-Tomero; Antonio Cirugeda; Erika de Sousa; Pilar Sandoval; Raquel Díaz; Manuel López-Cabrera; María Auxiliadora Bajo
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

Review 7.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 8.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

9.  Evaluation of enhanced peritoneum permeability in methylglyoxal-treated rats as a diagnostic method for peritoneal damage.

Authors:  Shintaro Fumoto; Yukiko Nakashima; Koyo Nishida; Yukinobu Kodama; Junya Nishi; Mikiro Nakashima; Hitoshi Sasaki; Noboru Otsuka; Junzo Nakamura
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

10.  Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology.

Authors:  Kazuho Honda; Chieko Hamada; Masaaki Nakayama; Masanobu Miyazaki; Ali M Sherif; Takashi Harada; Hiroshi Hirano
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.